Green Cross Lab Cell Corporation Cash Flow-to-Debt Ratio
Green Cross Lab Cell Corporation cash flow-to-debt ratio. Green Cross Lab Cell Corporation (144510) has a Cash Flow-to-Debt Ratio of 0.00x as of June 2026, meaning its operating cash flow of ₩208.25 Million could theoretically repay 0% of its total liabilities (₩145.87 Billion) in one year. Check 144510 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Green Cross Lab Cell Corporation (2015–2025)
Cash flow-to-debt ratio of Green Cross Lab Cell Corporation from 2015 to 2025. Historical debt coverage capacity for Green Cross Lab Cell Corporation across 11 annual periods. Check cash flow reinvestment rate of Green Cross Lab Cell Corporation to assess the company's total reinvestment commitment from operating cash flow.
Green Cross Lab Cell Corporation Cash Flow-to-Debt Ratio by Year (2015–2025)
Green Cross Lab Cell Corporation cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Green Cross Lab Cell Corporation. For the full cash flow conversion analysis, see cash efficiency ratio of Green Cross Lab Cell Corporation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | ₩9.19 Billion | ₩113.31 Billion | ▼ -13.8% |
| 2024 | 0.09x | ₩11.34 Billion | ₩120.56 Billion | ▲ +217.0% |
| 2023 | 0.03x | ₩3.67 Billion | ₩123.69 Billion | ▼ -93.8% |
| 2022 | 0.48x | ₩66.42 Billion | ₩138.07 Billion | ▲ +170.8% |
| 2021 | 0.18x | ₩23.91 Billion | ₩134.57 Billion | ▼ -43.0% |
| 2020 | 0.31x | ₩9.09 Billion | ₩29.19 Billion | ▲ +3254.2% |
| 2019 | 0.01x | ₩223.04 Million | ₩24.02 Billion | ▼ -81.9% |
| 2018 | 0.05x | ₩490.92 Million | ₩9.55 Billion | ▼ -87.4% |
| 2017 | 0.41x | ₩2.86 Billion | ₩7.03 Billion | ▲ +980.1% |
| 2016 | -0.05x | ₩-296.65 Million | ₩6.42 Billion | ▼ -124.6% |
| 2015 | 0.19x | ₩1.49 Billion | ₩7.90 Billion | — |